We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genentech Accuses Amgen of Ignoring Disclosure Requirements for Avastin Biosimilar
Genentech Accuses Amgen of Ignoring Disclosure Requirements for Avastin Biosimilar
Amgen neglected to provide Genentech with information on its manufacturing process for an Avastin biosimilar, violating statutory requirements, Genentech contends in a complaint.